Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03460522
What this trial is testing

Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia
Nicola Goekbuget 65
Large-scale testing (Phase 3)UnknownNCT02360761
What this trial is testing

Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy

Who this might be right for
Non-small Cell Lung Cancer
Peking University People's Hospital 339
Not applicableLooking for participantsNCT06740266
What this trial is testing

The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families

Who this might be right for
Parent Child RelationshipChild Social-Emotional DevelopmentTelomere Length+1 more
University of Washington 250
Not applicableActive Not RecruitingNCT06620666
What this trial is testing

NEUROmuscular Training for Enhanced AGE Longevity

Who this might be right for
AgingPhysical ActivityTraining
University of Valencia 390
Testing effectiveness (Phase 2)Study completedNCT00792623
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

Who this might be right for
Varicella
GlaxoSmithKline 45
Testing effectiveness (Phase 2)Study completedNCT00193401
What this trial is testing

Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Study completedNCT01576588
What this trial is testing

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Prof. Dr. Med. Laimonas Griskevicius 25
Testing effectiveness (Phase 2)Looking for participantsNCT06061146
What this trial is testing

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06921044
What this trial is testing

R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Xiaohui He 33
Not applicableStudy completedNCT03141957
What this trial is testing

Hypermetabolism in the Elderly Lung Cancer Patient

Who this might be right for
Non-small Cell Lung Carcinoma
University of Paris 5 - Rene Descartes 27
Testing effectiveness (Phase 2)Study completedNCT04313634
What this trial is testing

Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans

Who this might be right for
Healthy
Sundeep Khosla, M.D. 74
Post-approval studies (Phase 4)Ended earlyNCT03673332
What this trial is testing

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Who this might be right for
Advanced or Metastatic MelanomaAdvanced or Metastatic NSCLC
Institut Paoli-Calmettes 40
Large-scale testing (Phase 3)WithdrawnNCT05156632
What this trial is testing

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT06869265
What this trial is testing

Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)High Risk Acute Myeloid Leukemia(AML)Relapsed/Refractory Acute Myeloid Leukemia (AML)
Peking University People's Hospital 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770698
What this trial is testing

Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic Leukemia+9 more
BeOne Medicines 30
Not applicableStudy completedNCT05918185
What this trial is testing

Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 56
Not applicableStudy completedNCT01917591
What this trial is testing

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Who this might be right for
Punch Biopsy WoundsHealing Times
Kerecis Ltd. 81
Testing effectiveness (Phase 2)Looking for participantsNCT06187597
What this trial is testing

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 140
Large-scale testing (Phase 3)Looking for participantsNCT06734832
What this trial is testing

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

Who this might be right for
Hand, Foot, and Mouth Disease（HFMD)
Sinovac Biotech Co., Ltd 8,000
Not applicableStudy completedNCT02164071
What this trial is testing

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 363
Next Page